The present inventionrelates to the use of immunogenicpeptides comprising a T-cell epitopederived from a viral vector antigenand a redox motif such asC- (X)2--[CST] or [CST]-(X)2-C in thepre-vention and/or suppression ofim-mune responses to viral vectors andin the manufacture of medicamentstherefore.